Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 13 to 24 of 187 entries
Sorted by: Best Match Show Resources per page
APOL1 Kidney-Risk Variants Induce Mitochondrial Fission .

Kidney international reports

Ma L, Ainsworth HC, Snipes JA, Murea M, Choi YA, Langefeld CD, Parks JS, Bharadwaj MS, Chou JW, Hemal AK, Petrovic S, Craddock AL, Cheng D, Hawkins GA, Miller LD, Hicks PJ, Saleem MA, Divers J, Molina AJA, Freedman BI.
PMID: 32518871
Kidney Int Rep. 2020 Mar 30;5(6):891-904. doi: 10.1016/j.ekir.2020.03.020. eCollection 2020 Jun.

CONCLUSION: Results suggest the mitochondrial fusion/fission pathway may be a therapeutic target in

Cite
Ma L, Ainsworth HC, Snipes JA, et al. APOL1 Kidney-Risk Variants Induce Mitochondrial Fission . Kidney Int Rep. 2020;5(6):891-904doi: 10.1016/j.ekir.2020.03.020.
Ma, L., Ainsworth, H. C., Snipes, J. A., Murea, M., Choi, Y. A., Langefeld, C. D., Parks, J. S., Bharadwaj, M. S., Chou, J. W., Hemal, A. K., Petrovic, S., Craddock, A. L., Cheng, D., Hawkins, G. A., Miller, L. D., Hicks, P. J., Saleem, M. A., Divers, J., Molina, A. J. A., & Freedman, B. I. (2020). APOL1 Kidney-Risk Variants Induce Mitochondrial Fission . Kidney international reports, 5(6), 891-904. https://doi.org/10.1016/j.ekir.2020.03.020
Ma, Lijun, et al. "APOL1 Kidney-Risk Variants Induce Mitochondrial Fission ." Kidney international reports vol. 5,6 (2020): 891-904. doi: https://doi.org/10.1016/j.ekir.2020.03.020
Ma L, Ainsworth HC, Snipes JA, Murea M, Choi YA, Langefeld CD, Parks JS, Bharadwaj MS, Chou JW, Hemal AK, Petrovic S, Craddock AL, Cheng D, Hawkins GA, Miller LD, Hicks PJ, Saleem MA, Divers J, Molina AJA, Freedman BI. APOL1 Kidney-Risk Variants Induce Mitochondrial Fission . Kidney Int Rep. 2020 Mar 30;5(6):891-904. doi: 10.1016/j.ekir.2020.03.020. eCollection 2020 Jun. PMID: 32518871; PMCID: PMC7271005.
Copy Download .nbib Format: NLM
Hall effect in the two-dimensional metal Sr2RuO4.

Physical review. B, Condensed matter

Diver AJ, Fujita T, Hussey NE, Julian SR, Mackenzie AP, Maeno Y, Nishizaki S.
PMID: 9984367
Phys Rev B Condens Matter. 1996 Sep 01;54(10):7425-7429. doi: 10.1103/physrevb.54.7425.

No abstract available.

Cite
Diver AJ, Fujita T, Hussey NE, et al. Hall effect in the two-dimensional metal Sr2RuO4. Phys Rev B Condens Matter. 1996;54(10):7425-7429doi: 10.1103/physrevb.54.7425.
Diver, A. J., Fujita, T., Hussey, N. E., Julian, S. R., Mackenzie, A. P., Maeno, Y., & Nishizaki, S. (1996). Hall effect in the two-dimensional metal Sr2RuO4. Physical review. B, Condensed matter, 54(10), 7425-7429. https://doi.org/10.1103/physrevb.54.7425
Diver, et al. "Hall effect in the two-dimensional metal Sr2RuO4." Physical review. B, Condensed matter vol. 54,10 (1996): 7425-7429. doi: https://doi.org/10.1103/physrevb.54.7425
Diver AJ, Fujita T, Hussey NE, Julian SR, Mackenzie AP, Maeno Y, Nishizaki S. Hall effect in the two-dimensional metal Sr2RuO4. Phys Rev B Condens Matter. 1996 Sep 01;54(10):7425-7429. doi: 10.1103/physrevb.54.7425. PMID: 9984367.
Copy Download .nbib Format: NLM
Correction to: Advanced Robotic Therapy Integrated Centers (ARTIC): an international collaboration facilitating the application of rehabilitation technologies.

Journal of neuroengineering and rehabilitation

van Hedel HJA, Severini G, Scarton A, O'Brien A, Reed T, Gaebler-Spira D, Egan T, Meyer-Heim A, Graser J, Chua K, Zutter D, Schweinfurther R, Möller JC, Paredes LP, Esquenazi A, Berweck S, Schroeder S, Warken B, Chan A, Devers A, Petioky J, Paik NJ, Kim WS, Bonato P, Boninger M.
PMID: 29739468
J Neuroeng Rehabil. 2018 May 08;15(1):36. doi: 10.1186/s12984-018-0378-7.

The original article [1] contains a small mistake concerning the ARTIC Team members mentioned in the Acknowledgements. The team member, Rocco Salvatore Calabrò had their name presented incorrectly. This has now been corrected in the original article.

Cite
van Hedel HJA, Severini G, Scarton A, et al. Correction to: Advanced Robotic Therapy Integrated Centers (ARTIC): an international collaboration facilitating the application of rehabilitation technologies. J Neuroeng Rehabil. 2018;15(1):36doi: 10.1186/s12984-018-0378-7.
van Hedel, H. J. A., Severini, G., Scarton, A., O'Brien, A., Reed, T., Gaebler-Spira, D., Egan, T., Meyer-Heim, A., Graser, J., Chua, K., Zutter, D., Schweinfurther, R., Möller, J. C., Paredes, L. P., Esquenazi, A., Berweck, S., Schroeder, S., Warken, B., Chan, A., Devers, A., Petioky, J., Paik, N. J., Kim, W. S., Bonato, P., Boninger, M. (2018). Correction to: Advanced Robotic Therapy Integrated Centers (ARTIC): an international collaboration facilitating the application of rehabilitation technologies. Journal of neuroengineering and rehabilitation, 15(1), 36. https://doi.org/10.1186/s12984-018-0378-7
van Hedel, Hubertus J A, et al. "Correction to: Advanced Robotic Therapy Integrated Centers (ARTIC): an international collaboration facilitating the application of rehabilitation technologies." Journal of neuroengineering and rehabilitation vol. 15,1 (2018): 36. doi: https://doi.org/10.1186/s12984-018-0378-7
van Hedel HJA, Severini G, Scarton A, O'Brien A, Reed T, Gaebler-Spira D, Egan T, Meyer-Heim A, Graser J, Chua K, Zutter D, Schweinfurther R, Möller JC, Paredes LP, Esquenazi A, Berweck S, Schroeder S, Warken B, Chan A, Devers A, Petioky J, Paik NJ, Kim WS, Bonato P, Boninger M. Correction to: Advanced Robotic Therapy Integrated Centers (ARTIC): an international collaboration facilitating the application of rehabilitation technologies. J Neuroeng Rehabil. 2018 May 08;15(1):36. doi: 10.1186/s12984-018-0378-7. PMID: 29739468; PMCID: PMC5941668.
Copy Download .nbib Format: NLM
Perspectives on Implementing Quality Improvement Collaboratives Effectively: Qualitative Findings from the CHIPRA Quality Demonstration Grant Program.

Joint Commission journal on quality and patient safety

Burton RA, Peters RA, Devers KJ.
PMID: 29290242
Jt Comm J Qual Patient Saf. 2018 Jan;44(1):12-22. doi: 10.1016/j.jcjq.2017.08.004. Epub 2017 Sep 29.

BACKGROUND: The most frequently pursued intervention in the $100 million, 18-state Children's Health Insurance Program Reauthorization Act of 2009 (CHIPRA) quality demonstration (2010-2015) was quality improvement collaboratives, which 12 states offered to more than 300 primary care practices. A...

Cite
Burton RA, Peters RA, Devers KJ. Perspectives on Implementing Quality Improvement Collaboratives Effectively: Qualitative Findings from the CHIPRA Quality Demonstration Grant Program. Jt Comm J Qual Patient Saf. 2017;44(1):12-22doi: 10.1016/j.jcjq.2017.08.004.
Burton, R. A., Peters, R. A., & Devers, K. J. (2018). Perspectives on Implementing Quality Improvement Collaboratives Effectively: Qualitative Findings from the CHIPRA Quality Demonstration Grant Program. Joint Commission journal on quality and patient safety, 44(1), 12-22. https://doi.org/10.1016/j.jcjq.2017.08.004
Burton, Rachel A, et al. "Perspectives on Implementing Quality Improvement Collaboratives Effectively: Qualitative Findings from the CHIPRA Quality Demonstration Grant Program." Joint Commission journal on quality and patient safety vol. 44,1 (2018): 12-22. doi: https://doi.org/10.1016/j.jcjq.2017.08.004
Burton RA, Peters RA, Devers KJ. Perspectives on Implementing Quality Improvement Collaboratives Effectively: Qualitative Findings from the CHIPRA Quality Demonstration Grant Program. Jt Comm J Qual Patient Saf. 2018 Jan;44(1):12-22. doi: 10.1016/j.jcjq.2017.08.004. Epub 2017 Sep 29. PMID: 29290242.
Copy Download .nbib Format: NLM
A Comparison of Composite Reliability Estimators: Coefficient Omega Confidence Intervals in the Current Literature.

Educational and psychological measurement

Padilla MA, Divers J.
PMID: 29795872
Educ Psychol Meas. 2016 Jun;76(3):436-453. doi: 10.1177/0013164415593776. Epub 2015 Jul 08.

Coefficient omega and alpha are both measures of the composite reliability for a set of items. Unlike coefficient alpha, coefficient omega remains unbiased with congeneric items with uncorrelated errors. Despite this ability, coefficient omega is not as widely used...

Cite
Padilla MA, Divers J. A Comparison of Composite Reliability Estimators: Coefficient Omega Confidence Intervals in the Current Literature. Educ Psychol Meas. 2015;76(3):436-453doi: 10.1177/0013164415593776.
Padilla, M. A., & Divers, J. (2016). A Comparison of Composite Reliability Estimators: Coefficient Omega Confidence Intervals in the Current Literature. Educational and psychological measurement, 76(3), 436-453. https://doi.org/10.1177/0013164415593776
Padilla, Miguel A, and Divers, Jasmin. "A Comparison of Composite Reliability Estimators: Coefficient Omega Confidence Intervals in the Current Literature." Educational and psychological measurement vol. 76,3 (2016): 436-453. doi: https://doi.org/10.1177/0013164415593776
Padilla MA, Divers J. A Comparison of Composite Reliability Estimators: Coefficient Omega Confidence Intervals in the Current Literature. Educ Psychol Meas. 2016 Jun;76(3):436-453. doi: 10.1177/0013164415593776. Epub 2015 Jul 08. PMID: 29795872; PMCID: PMC5965559.
Copy Download .nbib Format: NLM
Subcutaneous Administration of Low-Molecular-Weight Heparin to Horses Inhibits Ex Vivo Equine Herpesvirus Type 1-Induced Platelet Activation.

Frontiers in veterinary science

Stokol T, Serpa PBS, Brooks MB, Divers T, Ness S.
PMID: 29892605
Front Vet Sci. 2018 May 28;5:106. doi: 10.3389/fvets.2018.00106. eCollection 2018.

Equine herpesvirus type 1 (EHV-1) is a major cause of infectious respiratory disease, abortion and neurologic disease. Thrombosis in placental and spinal vessels and subsequent ischemic injury in EHV-1-infected horses manifests clinically as abortion and myeloencephalopathy. We have previously...

Cite
Stokol T, Serpa PBS, Brooks MB, et al. Subcutaneous Administration of Low-Molecular-Weight Heparin to Horses Inhibits Ex Vivo Equine Herpesvirus Type 1-Induced Platelet Activation. Front Vet Sci. 2018;5:106doi: 10.3389/fvets.2018.00106.
Stokol, T., Serpa, P. B. S., Brooks, M. B., Divers, T., & Ness, S. (2018). Subcutaneous Administration of Low-Molecular-Weight Heparin to Horses Inhibits Ex Vivo Equine Herpesvirus Type 1-Induced Platelet Activation. Frontiers in veterinary science, 5106. https://doi.org/10.3389/fvets.2018.00106
Stokol, Tracy, et al. "Subcutaneous Administration of Low-Molecular-Weight Heparin to Horses Inhibits Ex Vivo Equine Herpesvirus Type 1-Induced Platelet Activation." Frontiers in veterinary science vol. 5 (2018): 106. doi: https://doi.org/10.3389/fvets.2018.00106
Stokol T, Serpa PBS, Brooks MB, Divers T, Ness S. Subcutaneous Administration of Low-Molecular-Weight Heparin to Horses Inhibits Ex Vivo Equine Herpesvirus Type 1-Induced Platelet Activation. Front Vet Sci. 2018 May 28;5:106. doi: 10.3389/fvets.2018.00106. eCollection 2018. PMID: 29892605; PMCID: PMC5985713.
Copy Download .nbib Format: NLM
Origin of Panchromaticity in Multichromophore-Tetrapyrrole Arrays.

The journal of physical chemistry. A

Yuen JM, Diers JR, Alexy EJ, Roy A, Mandal AK, Kang HS, Niedzwiedzki DM, Kirmaier C, Lindsey JS, Bocian DF, Holten D.
PMID: 30152691
J Phys Chem A. 2018 Sep 13;122(36):7181-7201. doi: 10.1021/acs.jpca.8b06815. Epub 2018 Aug 28.

Panchromatic absorbers that have robust photophysical properties enable new designs for molecular-based light-harvesting systems. Herein, we report experimental and theoretical studies of the spectral, redox, and excited-state properties of a series of perylene-monoimide-ethyne-porphyrin arrays wherein the number of perylene-monoimide...

Cite
Yuen JM, Diers JR, Alexy EJ, et al. Origin of Panchromaticity in Multichromophore-Tetrapyrrole Arrays. J Phys Chem A. 2018;122(36):7181-7201doi: 10.1021/acs.jpca.8b06815.
Yuen, J. M., Diers, J. R., Alexy, E. J., Roy, A., Mandal, A. K., Kang, H. S., Niedzwiedzki, D. M., Kirmaier, C., Lindsey, J. S., Bocian, D. F., & Holten, D. (2018). Origin of Panchromaticity in Multichromophore-Tetrapyrrole Arrays. The journal of physical chemistry. A, 122(36), 7181-7201. https://doi.org/10.1021/acs.jpca.8b06815
Yuen, Jonathan M, et al. "Origin of Panchromaticity in Multichromophore-Tetrapyrrole Arrays." The journal of physical chemistry. A vol. 122,36 (2018): 7181-7201. doi: https://doi.org/10.1021/acs.jpca.8b06815
Yuen JM, Diers JR, Alexy EJ, Roy A, Mandal AK, Kang HS, Niedzwiedzki DM, Kirmaier C, Lindsey JS, Bocian DF, Holten D. Origin of Panchromaticity in Multichromophore-Tetrapyrrole Arrays. J Phys Chem A. 2018 Sep 13;122(36):7181-7201. doi: 10.1021/acs.jpca.8b06815. Epub 2018 Aug 28. PMID: 30152691.
Copy Download .nbib Format: NLM
Remind Me To Remember: A pilot study of a novel smartphone reminder application for older adults with dementia and mild cognitive impairment.

Neuropsychological rehabilitation

Hackett K, Lehman S, Divers R, Ambrogi M, Gomes L, Tan CC, Giovannetti T.
PMID: 32684106
Neuropsychol Rehabil. 2020 Jul 20;1-29. doi: 10.1080/09602011.2020.1794909. Epub 2020 Jul 20.

The SmartPrompt is a smartphone-based reminder application informed by a neuropsychological model of functional disability. This laboratory-based pilot study examined the SmartPrompt feasibility, efficacy, and subjective usability using a within-participant, counterbalanced, cross-over design. Ten participants (

Cite
Hackett K, Lehman S, Divers R, et al. Remind Me To Remember: A pilot study of a novel smartphone reminder application for older adults with dementia and mild cognitive impairment. Neuropsychol Rehabil. 2020;1-29doi: 10.1080/09602011.2020.1794909.
Hackett, K., Lehman, S., Divers, R., Ambrogi, M., Gomes, L., Tan, C. C., & Giovannetti, T. (2020). Remind Me To Remember: A pilot study of a novel smartphone reminder application for older adults with dementia and mild cognitive impairment. Neuropsychological rehabilitation, 1-29. https://doi.org/10.1080/09602011.2020.1794909
Hackett, Katherine, et al. "Remind Me To Remember: A pilot study of a novel smartphone reminder application for older adults with dementia and mild cognitive impairment." Neuropsychological rehabilitation vol. (2020): 1-29. doi: https://doi.org/10.1080/09602011.2020.1794909
Hackett K, Lehman S, Divers R, Ambrogi M, Gomes L, Tan CC, Giovannetti T. Remind Me To Remember: A pilot study of a novel smartphone reminder application for older adults with dementia and mild cognitive impairment. Neuropsychol Rehabil. 2020 Jul 20;1-29. doi: 10.1080/09602011.2020.1794909. Epub 2020 Jul 20. PMID: 32684106; PMCID: PMC7854961.
Copy Download .nbib Format: NLM
Endoscopic Features of Mucous Cap Polyps: A Way to Predict Serrated Polyps.

Clinical endoscopy

Moy BT, Forouhar F, Kuo CL, Devers TJ.
PMID: 29699379
Clin Endosc. 2018 Jul;51(4):368-374. doi: 10.5946/ce.2017.155. Epub 2018 Apr 27.

BACKGROUND/AIMS: The aims of the study were to identify whether a mucous-cap predicts the presence of serrated polyps, and to determine whether additional endoscopic findings predict the presence of a sessile serrated adenomas/polyp (SSA/P).METHODS: We analyzed 147 mucous-capped polyps...

Cite
Moy BT, Forouhar F, Kuo CL, et al. Endoscopic Features of Mucous Cap Polyps: A Way to Predict Serrated Polyps. Clin Endosc. 2018;51(4):368-374doi: 10.5946/ce.2017.155.
Moy, B. T., Forouhar, F., Kuo, C. L., & Devers, T. J. (2018). Endoscopic Features of Mucous Cap Polyps: A Way to Predict Serrated Polyps. Clinical endoscopy, 51(4), 368-374. https://doi.org/10.5946/ce.2017.155
Moy, Brian T, et al. "Endoscopic Features of Mucous Cap Polyps: A Way to Predict Serrated Polyps." Clinical endoscopy vol. 51,4 (2018): 368-374. doi: https://doi.org/10.5946/ce.2017.155
Moy BT, Forouhar F, Kuo CL, Devers TJ. Endoscopic Features of Mucous Cap Polyps: A Way to Predict Serrated Polyps. Clin Endosc. 2018 Jul;51(4):368-374. doi: 10.5946/ce.2017.155. Epub 2018 Apr 27. PMID: 29699379; PMCID: PMC6078921.
Copy Download .nbib Format: NLM
[No title available]

Kidney international reports

Freedman BI, Moxey-Mims MM, Alexander AA, Astor BC, Birdwell KA, Bowden DW, Bowen G, Bromberg J, Craven TE, Dadhania DM, Divers J, Doshi MD, Eidbo E, Fornoni A, Gautreaux MD, Gbadegesin RA, Gee PO, Guerra G, Hsu CY, Iltis AS, Jefferson N, Julian BA, Klassen DK, Koty PP, Langefeld CD, Lentine KL, Ma L, Mannon RB, Menon MC, Mohan S, Moore JB, Murphy B, Newell KA, Odim J, Ortigosa-Goggins M, Palmer ND, Park M, Parsa A, Pastan SO, Poggio ED, Rajapakse N, Reeves-Daniel AM, Rosas SE, Russell LP, Sawinski D, Smith SC, Spainhour M, Stratta RJ, Weir MR, Reboussin DM, Kimmel PL, Brennan DC.
PMID: 32154449
Kidney Int Rep. 2019 Dec 13;5(3):278-288. doi: 10.1016/j.ekir.2019.11.022. eCollection 2020 Mar.

INTRODUCTION: Much of the higher risk for end-stage kidney disease (ESKD) in African American individuals relates to ancestry-specific variation in the apolipoprotein L1 gene (METHODS: APOLLO will evaluate outcomes from 2614 deceased kidney donor-recipient pairs, as well as additional...

Cite
Freedman BI, Moxey-Mims MM, Alexander AA, et al. . Kidney Int Rep. 2019;5(3):278-288doi: 10.1016/j.ekir.2019.11.022.
Freedman, B. I., Moxey-Mims, M. M., Alexander, A. A., Astor, B. C., Birdwell, K. A., Bowden, D. W., Bowen, G., Bromberg, J., Craven, T. E., Dadhania, D. M., Divers, J., Doshi, M. D., Eidbo, E., Fornoni, A., Gautreaux, M. D., Gbadegesin, R. A., Gee, P. O., Guerra, G., Hsu, C. Y., Iltis, A. S., Jefferson, N., Julian, B. A., Klassen, D. K., Koty, P. P., Langefeld, C. D., Lentine, K. L., Ma, L., Mannon, R. B., Menon, M. C., Mohan, S., Moore, J. B., Murphy, B., Newell, K. A., Odim, J., Ortigosa-Goggins, M., Palmer, N. D., Park, M., Parsa, A., Pastan, S. O., Poggio, E. D., Rajapakse, N., Reeves-Daniel, A. M., Rosas, S. E., Russell, L. P., Sawinski, D., Smith, S. C., Spainhour, M., Stratta, R. J., Weir, M. R., Reboussin, D. M., Kimmel, P. L., & Brennan, D. C. (2020). . Kidney international reports, 5(3), 278-288. https://doi.org/10.1016/j.ekir.2019.11.022
Freedman, Barry I, et al. "." Kidney international reports vol. 5,3 (2020): 278-288. doi: https://doi.org/10.1016/j.ekir.2019.11.022
Freedman BI, Moxey-Mims MM, Alexander AA, Astor BC, Birdwell KA, Bowden DW, Bowen G, Bromberg J, Craven TE, Dadhania DM, Divers J, Doshi MD, Eidbo E, Fornoni A, Gautreaux MD, Gbadegesin RA, Gee PO, Guerra G, Hsu CY, Iltis AS, Jefferson N, Julian BA, Klassen DK, Koty PP, Langefeld CD, Lentine KL, Ma L, Mannon RB, Menon MC, Mohan S, Moore JB, Murphy B, Newell KA, Odim J, Ortigosa-Goggins M, Palmer ND, Park M, Parsa A, Pastan SO, Poggio ED, Rajapakse N, Reeves-Daniel AM, Rosas SE, Russell LP, Sawinski D, Smith SC, Spainhour M, Stratta RJ, Weir MR, Reboussin DM, Kimmel PL, Brennan DC. . Kidney Int Rep. 2019 Dec 13;5(3):278-288. doi: 10.1016/j.ekir.2019.11.022. eCollection 2020 Mar. PMID: 32154449; PMCID: PMC7056919.
Copy Download .nbib Format: NLM
A randomized preference trial of cognitive-behavioral therapy and yoga for the treatment of worry in anxious older adults.

Contemporary clinical trials communications

Brenes GA, Divers J, Miller ME, Danhauer SC.
PMID: 30009275
Contemp Clin Trials Commun. 2018 May 04;10:169-176. doi: 10.1016/j.conctc.2018.05.002. eCollection 2018 Jun.

BACKGROUND: Worry is a common problem among older adults. Cognitive-behavioral therapy is the most studied nonpharmacological intervention and it has demonstrated efficacy in reducing late-life worry and anxiety. Although the evidence-base is smaller, yoga has been shown to reduce...

Cite
Brenes GA, Divers J, Miller ME, et al. A randomized preference trial of cognitive-behavioral therapy and yoga for the treatment of worry in anxious older adults. Contemp Clin Trials Commun. 2018;10:169-176doi: 10.1016/j.conctc.2018.05.002.
Brenes, G. A., Divers, J., Miller, M. E., & Danhauer, S. C. (2018). A randomized preference trial of cognitive-behavioral therapy and yoga for the treatment of worry in anxious older adults. Contemporary clinical trials communications, 10169-176. https://doi.org/10.1016/j.conctc.2018.05.002
Brenes, Gretchen A, et al. "A randomized preference trial of cognitive-behavioral therapy and yoga for the treatment of worry in anxious older adults." Contemporary clinical trials communications vol. 10 (2018): 169-176. doi: https://doi.org/10.1016/j.conctc.2018.05.002
Brenes GA, Divers J, Miller ME, Danhauer SC. A randomized preference trial of cognitive-behavioral therapy and yoga for the treatment of worry in anxious older adults. Contemp Clin Trials Commun. 2018 May 04;10:169-176. doi: 10.1016/j.conctc.2018.05.002. eCollection 2018 Jun. PMID: 30009275; PMCID: PMC6042466.
Copy Download .nbib Format: NLM
Prescribing of Statins After Lower Extremity Revascularization Procedures in the US.

JAMA network open

Singh N, Ding L, Devera J, Magee GA, Garg PK.
PMID: 34860245
JAMA Netw Open. 2021 Dec 01;4(12):e2136014. doi: 10.1001/jamanetworkopen.2021.36014.

IMPORTANCE: The use of statins in patients with symptomatic peripheral artery disease remains suboptimal despite strong clinical practice guideline recommendations; however, it is unknown whether rates are associated with substantial improvements after lower extremity revascularization.OBJECTIVE: To report longitudinal trends...

Cite
Singh N, Ding L, Devera J, et al. Prescribing of Statins After Lower Extremity Revascularization Procedures in the US. JAMA Netw Open. 2021;4(12):e2136014doi: 10.1001/jamanetworkopen.2021.36014.
Singh, N., Ding, L., Devera, J., Magee, G. A., & Garg, P. K. (2021). Prescribing of Statins After Lower Extremity Revascularization Procedures in the US. JAMA network open, 4(12), e2136014. https://doi.org/10.1001/jamanetworkopen.2021.36014
Singh, Nikhil, et al. "Prescribing of Statins After Lower Extremity Revascularization Procedures in the US." JAMA network open vol. 4,12 (2021): e2136014. doi: https://doi.org/10.1001/jamanetworkopen.2021.36014
Singh N, Ding L, Devera J, Magee GA, Garg PK. Prescribing of Statins After Lower Extremity Revascularization Procedures in the US. JAMA Netw Open. 2021 Dec 01;4(12):e2136014. doi: 10.1001/jamanetworkopen.2021.36014. PMID: 34860245; PMCID: PMC8642785.
Copy Download .nbib Format: NLM
Showing 13 to 24 of 187 entries